Hepatitis Monthly

Published by: Kowsar

Serial Liver Stiffness Measurements and Monitoring of Liver-Transplanted Patients in a Real-Life Clinical Practice

Luca Rinaldi 1 , Giovanna Valente 1 and Guido Piai 1 , *
Authors Information
1 Department of Medical and Surgical Oncology, Liver Unit, AORN S. Anna and S. Sebastiano, Caserta, Italy
Article information
  • Hepatitis Monthly: December 2016, 16 (12); e41162
  • Published Online: December 6, 2016
  • Article Type: Research Article
  • Received: July 31, 2016
  • Revised: October 15, 2016
  • Accepted: October 22, 2016
  • DOI: 10.5812/hepatmon.41162

To Cite: Rinaldi L, Valente G, Piai G. Serial Liver Stiffness Measurements and Monitoring of Liver-Transplanted Patients in a Real-Life Clinical Practice, Hepat Mon. 2016 ;16(12):e41162. doi: 10.5812/hepatmon.41162.

Abstract
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Banff Working Group on Liver Allograft P. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl. 2012; 18(10): 1154-70[DOI][PubMed]
  • 2. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986; 2(2): 165-73[PubMed]
  • 3. Cholongitas E, Tsochatzis E, Goulis J, Burroughs AK. Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review. Transpl Int. 2010; 23(9): 861-70[DOI][PubMed]
  • 4. Bonino F, Arena U, Brunetto MR, Coco B, Fraquelli M, Oliveri F, et al. Liver stiffness, a non-invasive marker of liver disease: a core study group report. Antivir Ther. 2010; 15 Suppl 3: 69-78[DOI][PubMed]
  • 5. Petta S, Maida M, Macaluso FS, Di Marco V, Camma C, Cabibi D, et al. The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology. 2015; 62(4): 1101-10[DOI][PubMed]
  • 6. Berzigotti A, Abraldes JG, Bosch J. Regarding "Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution". Hepatology. 2014; 59(1): 350-1[DOI][PubMed]
  • 7. Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008; 48(5): 1718-23[DOI][PubMed]
  • 8. Yashima Y, Tsujino T, Masuzaki R, Nakai Y, Hirano K, Tateishi R, et al. Increased liver elasticity in patients with biliary obstruction. J Gastroenterol. 2011; 46(1): 86-91[DOI][PubMed]
  • 9. Parsian H, Alizadeh M, Negahdar H. Would the physicians eventually obsolete the liver biopsy for the assessment of liver fibrosis? Hepat Mon. 2012; 12(5): 353-4[DOI][PubMed]
  • 10. European Association for Study of L, Asociacion Latinoamericana para el Estudio del H. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015; 63(1): 237-64[DOI][PubMed]
  • 11. Tapper EB, Castera L, Afdhal NH. FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. Clin Gastroenterol Hepatol. 2015; 13(1): 27-36[DOI][PubMed]
  • 12. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008; 48(5): 835-47[DOI][PubMed]
  • 13. Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013; 57(3): 1182-91[DOI][PubMed]
  • 14. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005; 128(2): 343-50[PubMed]
  • 15. Burra P, Mioni D, Cecchetto A, Cillo U, Zanus G, Fagiuoli S, et al. Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol. 2001; 34(5): 716-22[PubMed]
  • 16. Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol. 2009; 50(1): 1-3[DOI][PubMed]
  • 17. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006; 12(12): 1791-8[DOI][PubMed]
  • 18. Singh S, Fujii LL, Murad MH, Wang Z, Asrani SK, Ehman RL, et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013; 11(12): 1573-84 e1-2[DOI][PubMed]
  • 19. Crespo G, Lens S, Gambato M, Carrion JA, Marino Z, Londono MC, et al. Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C. Am J Transplant. 2014; 14(2): 375-83[DOI][PubMed]
  • 20. Malekzadeh R, Poustchi H. Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy. Hepat Mon. 2011; 11(3): 157-8[PubMed]
  • 21. Christiansen KM, Mossner BK, Hansen JF, Jarnbjer EF, Pedersen C, Christensen PB. Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study. PLoS One. 2014; 9(11): 111912[DOI][PubMed]
  • 22. Stasi C, Arena U, Zignego AL, Corti G, Monti M, Triboli E, et al. Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. Dig Liver Dis. 2013; 45(10): 840-3[DOI][PubMed]
  • 23. Calvaruso V, Di Marco V, Ferraro D, Petta S, Cali A, Grazia Bavetta M, et al. Fibrosis evaluation by transient elastography in patients with long-term sustained HCV clearance. Hepat Mon. 2013; 13(5): 7176[DOI][PubMed]
  • 24. O'Grady JG, Hardy P, Burroughs AK, Elbourne D, Ireland Liver Transplant Study G. Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. Am J Transplant. 2007; 7(1): 137-41[DOI][PubMed]
  • 25. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant. 2007; 7(6): 1506-14[DOI][PubMed]
  • 26. Vergniol J, Boursier J, Coutzac C, Bertrais S, Foucher J, Angel C, et al. Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology. 2014; 60(1): 65-76[DOI][PubMed]
  • 27. Corpechot C, Carrat F, Poujol-Robert A, Gaouar F, Wendum D, Chazouilleres O, et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology. 2012; 56(1): 198-208[DOI][PubMed]
  • 28. Mehta SH, Kirk GD, Astemborski J, Sulkowski MS, Afdhal NH, Thomas DL. Stability of liver fibrosis among HCV-infected injection drug users. Antivir Ther. 2012; 17(5): 813-21[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader